Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)

Purpose

Spinal muscular atrophy (SMA) is a neurogenetic disorder caused by a loss or mutation in the survival motor neuron 1 gene (SMN1) on chromosome 5q13, which leads to reduced SMN protein levels and a selective dysfunction of motor neurons. SMA is an autosomal recessive, early childhood disease with an incidence of 1:10,000 live births. SMA is the leading cause of infant mortality due to genetic diseases. The purpose of this registry is to assess the long term outcomes of patients with SMA in the context of advances in treatment options and also to characterize and assess long-term safety and effectiveness of OAV-101.

Condition

  • Spinal Muscular Atrophy (SMA)

Eligibility

Eligible Ages
All ages
Eligible Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Patients treated with OAV-101 with a genetically confirmed diagnosis of SMA regardless of the date of diagnosis. - Appropriate consent/assent has been obtained for participation in the registry

Exclusion Criteria

  • Currently enrolled in an interventional clinical trial involving an investigational medicinal product to treat SMA. Note: Patients who are participating in a Compassionate Use Program (CUP) for OAV-101 (Zolgensma) such as a Managed Access Program (MAP), an Expanded Access Program (EAP), Single Patient Investigational New Drug (IND) (SPI) or Named Patient Program (NPP) are eligible to enroll in the registry regardless of the date of a genetic or clinical diagnosis of SMA.

Study Design

Phase
Study Type
Observational [Patient Registry]
Observational Model
Ecologic or Community
Time Perspective
Prospective

Arm Groups

ArmDescriptionAssigned Intervention
Prospective observational registry This is a prospective, multi center, multinational, non-interventional observational registry.
  • Other: Prospective observational registry
    This prospective observational registry will assess long-term outcomes of patients with a diagnosis of SMA.
  • Drug: Zolgensma
    Zolgensma will be given to patients as per normal clinical practice and clinical care will not be mandated by the protocol. As such, the decision to prescribe Zolgensma is separate from the decision to include the patient in this study

Recruiting Locations

Phoenix Children's Hospital
Phoenix 5308655, Arizona 5551752 85016
Contact:
Alison Lane
602-933-0885
alane@phoenixchildrens.com

Arkansas Children's Hospital
Little Rock 4119403, Arkansas 4099753 72202
Contact:
Kapil Arya
501-364-1850
karya@uams.edu

Children's Hospital of Los Angeles
Los Angeles 5368361, California 5332921 90027
Contact:
Martha Arellano-Garcia
323-361-5812
margarcia@chla.usc.edu

University of California Los Angeles Health
Los Angeles 5368361, California 5332921 90095
Contact:
Huynh Jennifer
310-825-3564
JenniferH@mednet.ucla.edu

Valley Children's Healthcare
Madera 5369568, California 5332921 93636
Contact:
Raymund David, MD
559-353-6215
RDavid@valleychildrens.org

Children's Hospital of Orange County
Madera 5369568, California 5332921 93638
Contact:
Amanda Fernandez, MD
559-353-6215
afernandez@choc.org

University of California Davis Health System
Sacramento 5389489, California 5332921 95817
Contact:
Rachel (Ja Yoon) Baek
916-734-2439
jrbaek@ucdavis.edu

Rady Children's Hospital San Diego
San Diego 5391811, California 5332921 92123
Contact:
Chamindra Konersman, MD
858-966-5819
ckonersman@health.ucsd.edu

Children's Hospital Colorado
Aurora 5412347, Colorado 5417618 80045
Contact:
Margaret Finlay
720-777-1234
margaret.finlay@childrenscolorado.org

Connecticut Children's Medical Center
Farmington 4834272, Connecticut 4831725 06034
Contact:
Hendriana Nielsen
860-837-5881
HNielsen@connecticutchildrens.org

Yale-New Haven Health System
New Haven 4839366, Connecticut 4831725 06510
Contact:
Catherine Tsao
203-785-4390
catherine.tsao@yale.edu

Golisano Children's Hospital of Southwest Florida
Fort Myers 4155995, Florida 4155751 33908
Contact:
Britt Stroud, MD
239-343-5437
britt.stroud@leehealth.org

Jackson South Medical Center
Palmetto Bay 4167634, Florida 4155751 33157
Contact:
Paula Schleifer, MD
305-279-2226
pschleifer@fcneurology.net

Indiana University Health University Hospital (IUHUH)
Indianapolis 4259418, Indiana 4921868 46202
Contact:
Marcia Felker, MD
317-948-7450
mamccann@iupui.edu

University of Iowa
Iowa City 4862034, Iowa 4862182 52242-1009
Contact:
Chandra Miller
319-384-9618
Chandra-miller@uiowa.edu

University of Kansas Medical Center
Kansas City 4273837, Kansas 4273857 66160
Contact:
Rebecca Clay
913-588-1227
rclay@kumc.edu

University of Louisville
Louisville 4299276, Kentucky 6254925 40202
Contact:
Lauren Evanczyk
502-588-3650
Lauren.evanczyk@nortonhealthcare.org

University of Minnesota
Minneapolis 5037649, Minnesota 5037779 55455
Contact:
Seth Stafki, MD
218-298-2747
stafk006@umn.edu

University of Missouri Health System
Columbia 4381982, Missouri 4398678 65212
Contact:
Anne Bonnett
573-884-6119
bonnetta@health.missouri.edu

Washington University School of Medicine in St. Louis
St Louis 4407066, Missouri 4398678 63110
Contact:
Natalie Goedeker
314-362-4919
ngoedeker@wustl.edu

Atlantic Health System
Morristown 5101427, New Jersey 5101760 07960
Contact:
Darius Adams, MD
518-262-5120
adamsd@mail.amc.edu

University of Rochester Medical Center
Rochester 5134086, New York 5128638 14642
Contact:
Bohoon Lee
585-275-2776
Bohoon_Lee@URMC.Rochester.edu

The State University of New York
Stony Brook 5139865, New York 5128638 11794
Contact:
Christine Pol
631-444-9083
Christiana.Pol@stonybrookmedicine.edu

Duke Health
Durham 4464368, North Carolina 4482348 27705
Contact:
Karen Cornett
919-684-1143
k.cornett@duke.edu

Cincinnati Children's Hospital Medical Center
Cincinnati 4508722, Ohio 5165418 45229-3026
Contact:
Emily Hunsaker
513-636-5511
emily.hunsaker@cchmc.org

Nationwide Children's Hospital
Columbus 4509177, Ohio 5165418 43205
Contact:
Megan Waldrop
614-722-2231
Megan.WAldrop@nationwidechildrens.org

Oregon Health and Science University
Portland 5746545, Oregon 5744337 97239-3098
Contact:
Bryn McCarthy
503-418-8297
McCarbry@ohsu.edu

Penn State Hershey
Hershey 5193342, Pennsylvania 6254927 17033
Contact:
Ellen Stoute
717-531-1260
estoute@pennstatehealth.psu.edu

University of Pittsburgh Medical Center
Pittsburgh 5206379, Pennsylvania 6254927 15224
Contact:
Emma Sekscinski
302-393-6102
ecs112@pitt.edu

Prisma Health
Greenville 4580543, South Carolina 4597040 29615
Contact:
Addie Hunnicutt Hunnicutt
864-454-5110
ahunnicutt@ghs.org

Methodist Le Bonheur Healthcare
Memphis 4641239, Tennessee 4662168 38103
Contact:
Farimah Salami
901-287-4509
Farimah.Salami@lebonheur.org

Cook Children's
Fort Worth 4691930, Texas 4736286 76104
Contact:
Kayla Blough
682-319-5312
Kayla.blough@cookchildrens.org

Texas Children's Hospital
Houston 4699066, Texas 4736286 77030
Contact:
Felize Singleton
832-824-1640
felize.singleton@bcm.edu

CHRISTUS Health
San Antonio 4726206, Texas 4736286 78207
Contact:
Melissa Svoboda, MD
210-704-4715
melissa.svoboda@bcm.edu

University of Utah
Salt Lake City 5780993, Utah 5549030 84113
Contact:
Sarah Moldt
801-585-9399
sarah.moldt@hsc.utah.edu

University of Virginia Health System
Charlottesville 4752031, Virginia 6254928 22908
Contact:
Chelsea Masterson
434-297-5737
CDM5FA@hscmail.mcc.virginia.edu

Children's Hospital of The King's Daughters
Norfolk 4776222, Virginia 6254928 23507
Contact:
Cassandra Todd
757-846-1969
Cassandra.Todd@chkd.org

Virginia Commonwealth University Health System
Richmond 4781708, Virginia 6254928 23298
Contact:
Ana Rosa Rezeq
804-828-1445
Anarosa.rezeq@vcuhealth.org

Seattle Children's
Seattle 5809844, Washington 5815135 98105
Contact:
Marissa Robertson
206-987-5457
Marissa.Robertson@seattlechildrens.org

MultiCare Health System
Tacoma 5812944, Washington 5815135 98405
Contact:
Beky Stone
971-319-0237
Becky.Stone@multicare.org

University of Wisconsin
Madison 5261457, Wisconsin 5279468 53792
Contact:
Maggie Chilsen
608-263-2704
mchilsen@clinicaltrials.wisc.edu

Children's Hospital of Wisconsin
Milwaukee 5263045, Wisconsin 5279468 53226
Contact:
Rupa Nallamothu
414-955-0685
rnallamothu@mcw.edu

More Details

NCT ID
NCT04174157
Status
Recruiting
Sponsor
Novartis Pharmaceuticals

Study Contact

Novartis Gene Therapies
1-888-669-6682
novartis.email@novartis.com

Detailed Description

This is a prospective, multi center, multinational, non-interventional observational study. All patients will be managed according to the clinical site's normal clinical practice, i.e., the diagnostic and clinical treatment/practice process that a clinician chooses according to their clinical judgement for an SMA patient. Clinical care will not be driven by the protocol. No additional visits or investigations will be performed beyond normal clinical practice. Patients will be followed for 15 years from enrolment or until death, whichever is sooner.